Thoracolumbar Fascia Thickness in Chronic Stroke Patients
Launched by ANKARA UNIVERSITY · Jul 30, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a part of the body called the thoracolumbar fascia, which is a layer of tissue in the lower back, to see how thick it is in people who have had a stroke more than six months ago. The study aims to understand how the thickness and flexibility of this tissue relate to important abilities like balance, trunk (core) control, flexibility, and how independently someone can carry out daily activities after a stroke.
People who might be eligible for this study are adults between 40 and 70 years old who have been diagnosed with a stroke by a doctor, have a certain level of thinking ability (measured by a simple test), and have mild to moderate disability from their stroke. Participants will undergo non-invasive tests, including an ultrasound to measure the tissue thickness, and simple physical tests to check their balance, trunk movement, and independence in daily tasks. It’s important to note that people who can’t speak, have severe vision problems, other serious neurological conditions, or heart failure, or who are advised not to exercise, will not be able to join. This study is not yet recruiting participants but aims to help improve understanding of stroke recovery and support better rehabilitation strategies in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between 40 and 70 years old.
- • Being diagnosed with a stroke by a neurologist.
- • Scoring above 21 on the Montreal Cognitive Assessment Scale.
- • Scoring between 0 and 3 on the Modified Rankin Scale.
- • Being at least 6 months past the stroke
- Exclusion Criteria:
- • Inability to communicate verbally
- • Individuals with severe visual impairment, neurological disorders in addition to stroke, and/or congestive heart failure
- • Patients in whom exercise is not recommended.
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Süleyman Korkusuz, PhD
Study Chair
Atılım University
Büşra Seçkinoğulları Korkusuz, PhD
Principal Investigator
Ankara University
Ayşenur Özcan, MSc
Study Chair
Çankırı Karatekin University
Ali Mert Özcan, MSc
Study Chair
Baskent University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported